- Home
- GRML
as of 10-22-2026 3:43pm EST
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | OMAHA |
| Market Cap: | 29.2M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 7.7M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | annual |
| EPS: | -0.16 | EPS Growth: | 31.25 |
| 52 Week Low/High: | $0.16 - $18.21 | Next Earning Date: | 11-12-2026 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
| P/E Ratio: | -38.63 | Index: | N/A |
| Free Cash Flow: | N/A | FCF Growth: | N/A |
AI-Powered GRML Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Greenland Mines Ltd. Common Stock (GRML)
Other
Avg Cost/Share
$9.35
Shares
3,500
Total Value
$32,727.10
Owned After
0
SEC Form 4
Chief Financial Officer
Avg Cost/Share
$9.72
Shares
14,000
Total Value
$136,080.00
Owned After
110,406
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| El-Dada Riad Hussein | GRML | Other | Oct 1, 2026 | Sell | $9.35 | 3,500 | $32,727.10 | 0 | |
| LeBlanc Jeff | GRML | Chief Financial Officer | Aug 25, 2026 | Buy | $9.72 | 14,000 | $136,080.00 | 110,406 |
Compare GRML vs Leading Stocks
See how GRML stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "GRML Greenland Mines Ltd. Common Stock - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.